TY - JOUR T1 - Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. AU - Laurikainen,Eija, AU - Valpas,Antti, AU - Kivelä,Aarre, AU - Kalliola,Tuomo, AU - Rinne,Kirsi, AU - Takala,Teuvo, AU - Nilsson,Carl Gustaf, PY - 2007/1/2/pubmed PY - 2007/2/16/medline PY - 2007/1/2/entrez SP - 4 EP - 11 JF - Obstetrics and gynecology JO - Obstet Gynecol VL - 109 IS - 1 N2 - OBJECTIVE: To compare the intraoperative and immediate postoperative performance of the retropubic tension-free vaginal tape (TVT) procedure with that of the transobturator tension-free vaginal tape (TVT-O) procedure as primary treatment for female urinary stress incontinence. METHODS: Randomized multicenter comparative trial including four university hospitals and three central hospitals in Finland. Assessment preoperatively and 2 months postoperatively included a cough stress test and the following condition-specific quality of life questionnaires: the Urinary Incontinence Severity Score (UISS), the Detrusor Instability Score, the Incontinence Impact Questionnaire-Short Form, the Urogenital Distress Inventory-Short Form, and a visual analog scale (VAS). Operation time, theater time, hospital stay, intraoperative and immediate postoperative complications were recorded. RESULTS: Of the 273 originally randomized patients, 267 underwent the allocated operation, 136 in the TVT group and 131 in the TVT-O group. No significant differences in objective or subjective cure rates were detected. Patients in the TVT-O group had a significantly longer hospital stay, needed significantly more postoperative opiate analgesia and had significantly more complications than the patients in the TVT group. Patients in both groups had a significant postoperative improvement in quality of life, as indicated by the results of all the questionnaires used, with no difference between the groups. CONCLUSION: The TVT and the TVT-O procedures perform equally in terms of objective and subjective cure. The statistically significant higher complication rate in the TVT-O group is not regarded as clinically significant. CLINICAL TRIAL REGISTRATION: (www.ClinicalTrials.gov), NCT00379314 LEVEL OF EVIDENCE: I. SN - 0029-7844 UR - https://www.unboundmedicine.com/medline/citation/17197581/Retropubic_compared_with_transobturator_tape_placement_in_treatment_of_urinary_incontinence:_a_randomized_controlled_trial_ L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linkout&SEARCH=17197581.ui DB - PRIME DP - Unbound Medicine ER -